Share on LinkedInShare on LinkedIn

ARTICLE · 26 SEPTEMBER 2019

Pharmaceutical Antitrust 2019 – India

AZB & Partners
AZB & Partners
Contributor
AZB & Partners

AZB & Partners

AZB & Partners, one of India’s premier law firms was founded in 2004 with a clear purpose to...

View firm profile
Explore more from AZB & Partners

The legislative framework for the marketing, authorisation and pricing of pharmaceutical products in India (including generic drugs) consists of ...

IndiaAntitrust/Competition Law

Regulatory framework and authorities

1. What is the applicable regulatory framework for the authorisation, pricing and marketing of pharmaceutical products, including generic drugs?

The legislative framework for the marketing, authorisation and pricing of pharmaceutical products in India (including generic drugs) consists of:

  • the Drugs and Cosmetics Act 1940 (DCA), the Drugs and Cosmetics Rules 1945 (DCA Rules) and the Drugs (Control) Act 1950, which regulate the manufacture and distribution of pharmaceutical products;
  • the Drugs (Price Control) Order 2013 (DPCO), framed under the Essential Commodities Act 1955, which regulates the pricing of certain essential medicines listed therein;

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from